ChromoGenics AB (CHRO.ST)
SEK 9.8
(0.2%)
SEK 9.8
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -40.83 Million | -59.31 Million | -58.75 Million | -49.74 Million | -61.55 Million | -62.78 Million |
| Net Income | -52.5 Million | -55.92 Million | -59.65 Million | -56.77 Million | -74.89 Million | -72.05 Million |
| Depreciation & Amortization | 4.47 Million | 3.37 Million | 2.28 Million | 4.98 Million | 7.92 Million | 6.53 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.5 Million | -5.84 Million | 2.49 Million | 6.15 Million | 8.37 Million | 4.12 Million |
| Other non-cash items | 17.39 Million | -919 Thousand | -3.88 Million | -4.1 Million | -2.95 Million | -1.39 Million |
| Investing Cash Flow | -136 Thousand | -4.89 Million | -15.99 Million | -20.64 Million | -68.8 Million | -5.99 Million |
| Investments in PPE | -136 Thousand | -4.93 Million | -15.99 Million | -20.68 Million | -68.95 Million | -6.4 Million |
| Acquisitions | - | 38 Thousand | - | 40 Thousand | 150 Thousand | 411 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1000.00 | -4.98 Million | -1.18 Million | 150 Thousand | 411 Thousand |
| Financing Cash Flow | 24.77 Million | 69.48 Million | 204 Thousand | 138.92 Million | 147.69 Million | 37.83 Million |
| Debt repayment | - | -277 Thousand | -102 Thousand | -1.86 Million | -12.66 Million | -12.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 24.77 Million | 69.76 Million | 306 Thousand | 140.79 Million | 160.36 Million | 25.23 Million |
| Other Financing Activities | 24.77 Million | 69.48 Million | 204 Thousand | 138.92 Million | 147.69 Million | 12.6 Million |
| Accounts receivables | 67 Thousand | 6.11 Million | -3.76 Million | 8.66 Million | -8.05 Million | -2.62 Million |
| Accounts payables | -5.84 Million | 840 Thousand | -377 Thousand | -13.44 Million | 15.65 Million | -1.49 Million |
| Inventory | 24 Thousand | 813 Thousand | -2.76 Million | -1.49 Million | 671 Thousand | -1.29 Million |
| Other working capital | 10.25 Million | -13.6 Million | 9.4 Million | 12.42 Million | 101 Thousand | 5.42 Million |
| Cash at beginning of period | 24.12 Million | 18.85 Million | 93.39 Million | 24.85 Million | 7.52 Million | 38.46 Million |
| Cash at end of period | 7.92 Million | 24.12 Million | 18.85 Million | 93.39 Million | 24.85 Million | 7.52 Million |
| Capital Expenditure | -136 Thousand | -4.93 Million | -15.99 Million | -20.68 Million | -68.95 Million | -6.4 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -16.2 Million | 5.27 Million | -74.53 Million | 68.54 Million | 17.32 Million | -30.94 Million |
| Free Cash Flow | -40.97 Million | -64.24 Million | -74.74 Million | -70.42 Million | -130.51 Million | -69.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.51 Million | -13.6 Million | -16.59 Million | -52.5 Million | -9.95 Million | -11.08 Million |
| Depreciation & Amortization | 1.1 Million | 1.11 Million | 1.98 Million | 4.47 Million | 710 Thousand | 890 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.92 Million | -449 Thousand | 2.81 Million | 4.5 Million | 5.24 Million | -4.64 Million |
| Other non-cash items | -45.81 Million | 4.24 Million | 2.55 Million | 17.39 Million | 1.41 Million | -304 Thousand |
| Investing Cash Flow | 1.9 Million | -142 Thousand | 14 Thousand | -136 Thousand | 222 Thousand | -193 Thousand |
| Investments in PPE | 142 Thousand | -142 Thousand | - | -136 Thousand | -136 Thousand | -193 Thousand |
| Acquisitions | 1.76 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -79 Thousand | 14 Thousand | - | 358 Thousand | -193 Thousand |
| Financing Cash Flow | 16.37 Million | 6.68 Million | -876 Thousand | 24.77 Million | 17.03 Million | 4.33 Million |
| Debt repayment | -241 Thousand | -6.68 Million | -891 Thousand | - | -2.1 Million | -4.33 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 16.13 Million | - | 15 Thousand | 24.77 Million | 19.14 Million | - |
| Other Financing Activities | - | - | 50 Thousand | 24.77 Million | 20.75 Million | 4.33 Million |
| Accounts receivables | 5.44 Million | -2.51 Million | 701 Thousand | 67 Thousand | -464 Thousand | 136 Thousand |
| Accounts payables | -1.45 Million | 2.31 Million | -999 Thousand | -5.84 Million | -1.86 Million | -2.92 Million |
| Inventory | 1.3 Million | -720 Thousand | 1.97 Million | 24 Thousand | -130 Thousand | -1.37 Million |
| Other working capital | -2.37 Million | 470 Thousand | 1.14 Million | 10.25 Million | 7.7 Million | -487 Thousand |
| Cash at beginning of period | 2.62 Million | 7.92 Million | 20.32 Million | 24.12 Million | 5.65 Million | 16.65 Million |
| Cash at end of period | 4.72 Million | 2.62 Million | 7.92 Million | 7.92 Million | 20.32 Million | 5.65 Million |
| Capital Expenditure | 142 Thousand | -142 Thousand | - | -136 Thousand | -136 Thousand | -193 Thousand |
| Effect of forex changes on cash | - | - | 1000.00 | - | - | - |
| Net cash flow / Change in cash | 2.1 Million | -5.29 Million | -12.39 Million | -16.2 Million | 14.66 Million | -11 Million |
| Free Cash Flow | -16.04 Million | -11.98 Million | -11.53 Million | -40.97 Million | -2.72 Million | -15.34 Million |
ATCMF
605169
CWGL
AEV
HALMY
0709